相关实验视频

Updated: May 23, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

997

在高级非小细胞肺癌中进行生物标志物测试的成本:一项全球性研究,比较下一代测序和单基因测试

Umberto Malapelle1, Chien-Chin Chen2, Enrique de Álava3,4

  • 1Department of Public Health, University of Naples Federico II, Naples, Italy.

The journal of pathology. Clinical research
|March 7, 2025
PubMed
概括

下一代测序 (NGS) 在测试多个生物标志物时,为高级非小细胞肺癌 (aNSCLC) 提供了比单基因测试 (SGT) 的成本节省. 这项全球研究表明,随着时间的推移,NGS变得更具成本效益,支持更广泛的采用高效的医疗资源使用.

关键词:
在NSCLCLC中,我们可以看到.成本比较 成本比较这是下一代测序.精准医学是一门精准医学.预测性的生物标志物单基因测试是一种单基因测试.

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.8K